We reviewed the medical records of patients with pheochromocytoma diag
nosed in our institution, to confirm the high frequency of association
between pheochromocytoma and neurofibromatosis that we had found in a
previous study, and to compare the main clinical and pathological fea
tures of sporadic tumors and those with familial occurrence. Fourteen
patient (8 women and 6 men) with mean age 43.1 +/- 12.3 years were stu
dies. They were separated into group I: sporadic tumors (n = 9) and gr
oup II: tumors associated with familial syndromes (n = 6). The clinica
l features, biochemical results (from measurements of 24-hour urinary
vanilymandelic acid, catecholamines and metanephrines), and location a
nd size of the tumor were compared between both groups. One patient ha
d a malignant pheochromocytoma, another had bilateral tumors and a thi
rd patient had an extra-adrenal pheochromocytoma. Neurofibromatosis oc
curred in association with pheochromocytoma in 4 of 14 patients (28,5
%), and MEN II was diagnosed in another. We have found no differences
between the two groups except time to diagnosis that was shorter in th
e group with familial occurrence (6.4 +/- 9 vs 56.7 +/- 47 months; p =
0.039). The present study confirms the high frequency of pheochromocy
toma associated with neurofibromatosis in our country. These data sugg
est the need for pheochromocytoma screening in patient with neurofibro
matosis and their families.